Peboctocogene camaparvovec

DB16812InvestigationalGene Therapies

Peboctocogene camaparvovec: Overview.

Code names
BAY-2599023 · DTX-201

Resolves to

Compound
UNIICFE96HL6SKCAS2408734-39-2

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Peboctocogene camaparvovec, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In